Tian Lu

742 total citations
25 papers, 260 citations indexed

About

Tian Lu is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Tian Lu has authored 25 papers receiving a total of 260 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 12 papers in Hematology and 3 papers in Genetics. Recurrent topics in Tian Lu's work include Protein Degradation and Inhibitors (12 papers), Multiple Myeloma Research and Treatments (10 papers) and Ubiquitin and proteasome pathways (6 papers). Tian Lu is often cited by papers focused on Protein Degradation and Inhibitors (12 papers), Multiple Myeloma Research and Treatments (10 papers) and Ubiquitin and proteasome pathways (6 papers). Tian Lu collaborates with scholars based in China, United States and Bangladesh. Tian Lu's co-authors include Cheng Luo, Wenchao Lu, Kaixian Chen, Hualiang Jiang, Sen-Hao Xiao, Yujun Zhao, Hao Jiang, Ziqin Yan, Bing Zhou and Feilong Zhou and has published in prestigious journals such as PLoS ONE, Analytical Chemistry and Journal of Medicinal Chemistry.

In The Last Decade

Tian Lu

21 papers receiving 257 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tian Lu China 10 207 101 35 30 12 25 260
Huarui Cui United States 7 183 0.9× 107 1.1× 35 1.0× 36 1.2× 11 0.9× 10 250
Jen-Shin Song Taiwan 10 111 0.5× 64 0.6× 86 2.5× 24 0.8× 7 0.6× 14 254
Angeliki Thanasopoulou Switzerland 7 280 1.4× 166 1.6× 10 0.3× 35 1.2× 18 1.5× 11 316
Gody Khambatta United States 6 134 0.6× 70 0.7× 39 1.1× 40 1.3× 5 0.4× 9 204
Liyan Yue China 11 152 0.7× 28 0.3× 30 0.9× 20 0.7× 21 1.8× 16 219
Jason Marineau United States 7 259 1.3× 56 0.6× 56 1.6× 70 2.3× 14 1.2× 15 327
Chelsea E. Powell United States 7 351 1.7× 65 0.6× 38 1.1× 157 5.2× 13 1.1× 8 400
Anjali Cremer Germany 5 65 0.3× 60 0.6× 17 0.5× 32 1.1× 10 0.8× 12 140
Jacqueline L. Norris‐Drouin United States 11 362 1.7× 36 0.4× 40 1.1× 85 2.8× 9 0.8× 20 392
Carlo Lanza Switzerland 4 190 0.9× 349 3.5× 15 0.4× 37 1.2× 17 1.4× 5 440

Countries citing papers authored by Tian Lu

Since Specialization
Citations

This map shows the geographic impact of Tian Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tian Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tian Lu more than expected).

Fields of papers citing papers by Tian Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tian Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tian Lu. The network helps show where Tian Lu may publish in the future.

Co-authorship network of co-authors of Tian Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Tian Lu. A scholar is included among the top collaborators of Tian Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tian Lu. Tian Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gruber, Susan, Haitao Chu, Shiowjen Lee, et al.. (2025). Use of Real‐World Data and Real‐World Evidence in Rare Disease Drug Development: A Statistical Perspective. Clinical Pharmacology & Therapeutics. 117(4). 946–960. 2 indexed citations
2.
Tang, Junwen, et al.. (2025). A Broadband Dual Circularly Polarized Transmitarray With Independent Beam Control. IEEE Antennas and Wireless Propagation Letters. 24(9). 2824–2828.
3.
4.
Liu, Yuxiu, et al.. (2025). The selection and application of tiller number QTLs in modern wheat breeding. Theoretical and Applied Genetics. 138(6). 124–124.
5.
Sun, Chen, Yuqing Shen, Fuhua Wang, Tian Lu, & Jianqiong Zhang. (2025). Sympathetic nervous system in tumor progression and metabolic regulation: mechanisms and clinical potential. Journal of Translational Medicine. 23(1). 836–836. 2 indexed citations
6.
Yan, Xiang, et al.. (2024). Immune thrombocytopenia: a review of pathogenesis and current treatment. Discover Medicine. 1(1). 2 indexed citations
7.
Huang, Xueqin, et al.. (2024). Meta-analysis of machine learning models for the diagnosis of central precocious puberty based on clinical, hormonal (laboratory) and imaging data. Frontiers in Endocrinology. 15. 1353023–1353023. 2 indexed citations
8.
Zhang, Ya, Tian Lu, Lei Li, et al.. (2024). Qualitative analysis of chemical constituents and study on the biological activity of Polygonum perfoliatum L. Natural Product Research. 40(6). 1477–1484.
9.
Li, Y, Tian Lu, Ying Zhang, & Yigong Shi. (2023). Structural insights into CED-3 activation. Life Science Alliance. 6(9). e202302056–e202302056. 4 indexed citations
10.
Lu, Tian, Panyu Chen, Yaxi Yang, et al.. (2022). Cyclization strategy leads to highly potent Bromodomain and extra-terminal (BET) Bromodomain inhibitors for the treatment of acute liver injury. European Journal of Medicinal Chemistry. 247. 115023–115023. 7 indexed citations
11.
Zhu, Kongkai, Zhangbiao Long, Huimin Zhang, et al.. (2022). Targeting the RT loop of Src SH3 in Platelets Prevents Thrombosis without Compromising Hemostasis. Advanced Science. 9(7). e2103228–e2103228. 7 indexed citations
12.
Lu, Tian, Haibo Lu, Z. H. Duan, et al.. (2021). Discovery of High-Affinity Inhibitors of the BPTF Bromodomain. Journal of Medicinal Chemistry. 64(16). 12075–12088. 12 indexed citations
13.
Du, Daohai, Y. Liu, Tian Lu, et al.. (2021). Discovery and characterization of a novel glucose-6-phosphate dehydrogenase (G6PD) inhibitor via high-throughput screening. Bioorganic & Medicinal Chemistry Letters. 40. 127905–127905. 9 indexed citations
14.
Chen, Yu, Pan Xu, Hao Jiang, et al.. (2020). Design, synthesis, and biological evaluation of tetrahydroquinolin derivatives as potent inhibitors of CBP bromodomain. Bioorganic Chemistry. 101. 103991–103991. 12 indexed citations
15.
Chen, Yu, Wenchao Lu, Pan Xu, et al.. (2020). Structure-based drug optimization and biological evaluation of tetrahydroquinolin derivatives as selective and potent CBP bromodomain inhibitors. Bioorganic & Medicinal Chemistry Letters. 30(22). 127480–127480. 8 indexed citations
16.
Fan, Wenhui, Ying Cao, He Zhang, et al.. (2020). Robust induction of interferon and interferon-stimulated gene expression by influenza B/Yamagata lineage virus infection of A549 cells. PLoS ONE. 15(4). e0231039–e0231039. 7 indexed citations
17.
Chen, Deheng, Tian Lu, Ziqin Yan, et al.. (2019). Discovery, structural insight, and bioactivities of BY27 as a selective inhibitor of the second bromodomains of BET proteins. European Journal of Medicinal Chemistry. 182. 111633–111633. 45 indexed citations
18.
Liao, Liping, Yu Zuo, Dan Zhang, et al.. (2019). Discovery of novel CBP bromodomain inhibitors through TR-FRET-based high-throughput screening. Acta Pharmacologica Sinica. 41(2). 286–292. 13 indexed citations
19.
Zhang, Dan, Jie Han, Wenchao Lu, et al.. (2019). Discovery of alkoxy benzamide derivatives as novel BPTF bromodomain inhibitors via structure-based virtual screening. Bioorganic Chemistry. 86. 494–500. 13 indexed citations
20.
Lu, Tian, Junchi Hu, Wenchao Lu, et al.. (2018). Identification of small molecule inhibitors targeting the SMARCA2 bromodomain from a high-throughput screening assay. Acta Pharmacologica Sinica. 39(9). 1544–1552. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Huarui Cui Breakdown of academic impact, for papers by Jen-Shin Song Breakdown of academic impact, for papers by Angeliki Thanasopoulou Breakdown of academic impact, for papers by Gody Khambatta Breakdown of academic impact, for papers by Liyan Yue Breakdown of academic impact, for papers by Jason Marineau Breakdown of academic impact, for papers by Chelsea E. Powell Breakdown of academic impact, for papers by Anjali Cremer Breakdown of academic impact, for papers by Jacqueline L. Norris‐Drouin Breakdown of academic impact, for papers by Carlo Lanza
Rankless by CCL
2026